Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Recruiting · NCT07418125 · Interventional (participants receive a specific treatment) · Lead sponsor: Institute of Oncology Ljubljana
View the official record on ClinicalTrials.gov →Interventions studied
Liquid biopsy
What this trial is about
CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)
- Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C
- Adequate health status for neoadjuvant systemic treatment
Exclusion criteria
- Inflammatory breast cancer stage IV
- Luminal A, luminal B subtypes of non-inflammatory breast cancer
- Stages I-IIA breast cancer
- Inability to understand or communicate in Slovenian
- Inability to follow protocol instructions
- Inappropriate health status for chemotherapy treatment
- Primary treatment with surgery
Where it is running
1 location listed.
- Institute of Oncology Ljubljana - Ljubljana, Slovenia